Clostridium difficile Infection: An Integrated Review of Microbiology and Internal Medicine

Abstract

Clostridium difficile infection (CDI) is an important cause of antibiotic-associated diarrhea and healthcare-associated gastrointestinal disease. Between 2009 and 2014, understanding of CDI changed considerably as epidemic strains, molecular diagnostic methods, disruption of the intestinal microbiome, new antimicrobial agents, and microbiota-based therapies became increasingly important. The disease represents a close interface between clinical microbiology and Internal Medicine. Microbiologically, C. difficile is an anaerobic, spore-forming, toxin-producing organism whose pathogenicity is largely mediated by toxins A and B. Antibiotic-induced disruption of intestinal colonization resistance permits expansion of toxigenic organisms, while environmentally resistant spores facilitate transmission and recurrence. Clinically, disease ranges from mild diarrhea to pseudomembranous colitis, toxic megacolon, sepsis, and death. Accurate diagnosis requires correlation of compatible symptoms with laboratory findings because detection of a toxigenic organism alone cannot reliably distinguish active infection from asymptomatic colonization. During the reviewed period, multistep diagnostic algorithms incorporating glutamate dehydrogenase, toxin immunoassays, and nucleic-acid amplification became increasingly important. Treatment was guided by disease severity and recurrence, with metronidazole and oral vancomycin forming the traditional therapeutic foundation and fidaxomicin emerging as an alternative associated with lower recurrence in selected patients. Fecal microbiota transplantation provided compelling evidence that restoration of the intestinal microbial ecosystem can successfully treat recurrent disease. This review integrates the microbiological mechanisms, diagnostic principles, clinical manifestations, medical management, recurrence, and infection-control considerations of CDI using literature published between 2009 and 2014.